Select Page

Lung Cancer News From 2023
“In honor of November being Lung Cancer Awareness Month, here is a look back at some of the most impactful developments in the space from 2023.”

20-year study shows that lung cancer screening boosts survival rates
“Diagnosing early-stage lung cancer with low-dose CT (LDCT) translates to a 20-year survival rate of 81%, according to a large-scale, 20-year international study published November 7 in Radiology.”

Adverse Effect Management in Non–Small Cell Lung Cancer Treatment
“Adverse effects (AEs) relating to osimertinib (Tagrisso) and amivantamab (Rybrevant) were discussed as part of an Around the Practice: Institutional Insights program. Misako Nagasaka, MD, PhD, and Kristen Neumann, DNP, FNP-C, met to review AEs that they encounter during treatment cycles.”

Trilaciclib Snags ASCO Recommendation in Extensive-Stage Small Cell Lung Cancer
“In updated guidelines, the American Society of Clinical Oncology (ASCO) now recommend trilaciclib (Cosela) as a myeloid supportive agent for patients with untreated or previously treated extensive-stage small cell lung cancer (SCLC) who are receiving chemotherapy or chemoimmunotherapy.1,2

Genetics of Nearby Healthy Tissue May Help Catch Lung Cancer’s Return
“Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center”.

OHSU brings new tools in fight against lung cancer
“Lung cancer is a notorious killer. According to the American Cancer Society, the disease fells more than 125,000 Americans every year — more than colon, breast and prostate cancer combined. For many years, the prognosis was bleak and survival rates were distressingly low.”

How Quitting Smoking Can Affect Lung Cancer Outcomes
“When it comes to lung cancer, you might be surprised to learn that quitting smoking not only lowers your risk of developing cancer in the first place but also promotes better treatment outcomes.”